An analysis of five years of U.S. maternal mortality data reveals significant state-to-state differences in causes of death.

A randomized control trial found that postpartum women treated with nifedipine had a dramatically lower readmission rate than those on labetalol.

A retrospective study found that preconception use of GLP-1 medications was associated with reduced risks of several adverse pregnancy outcomes.

A study comparing sisters of women with and without pregnancy complications found that genetic and environmental factors may drive cardiovascular disease risk.

New techniques in managing maternal blood pressure are emerging.

Research shows the causes of maternal mortality differ widely from state to state.

One blood pressure medication outperformed another, potentially lowering postpartum readmission rates.

The Trump administration’s removal of CDC pages is disrupting detailed contraceptive guidelines.

An intimate essay describes the overwhelming stress of a high-risk pregnancy designation.

A review of over 90,000 drug trials shows that pregnant women are almost entirely excluded.

A new study suggests a blood test might help predict postpartum depression risk.

A report highlights confusion over Tennessee’s recent Medicaid expansion for postpartum care.

A study underscores that preventing preeclampsia is key to reducing serious postpartum complications.

 A study published in JAMA found cannabis use during pregnancy is associated with immediate risks, such as low birth weight and preterm birth.

Advances in neonatal care now make it possible to save extremely premature babies, some born as early as 22 weeks.

Donald Trump has nominated Dr. Mehmet Oz to lead Medicare and Medicaid–the country’s massive health insurance programs for the elderly and lower-income adults and children.